Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

NCT00684099

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • "IASO" General Hospital of Athnes, Dep of Medical Oncology Athens, Greece
  • "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
  • Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece
View Trial Details
Completed

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

NCT00615758

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • 401 Military Hospital, Medical Oncology Unit Athens, Greece
  • Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece
  • IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece
  • Sotiria" General Hospital, 2nd Dep of Pulmonary Diseases Athens, Greece
View Trial Details
Completed

To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT00191191

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ehime, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fukuoka, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Gifu, Japan
View all 16 locations
View Trial Details
Completed

Non-small Cell Lung Cancer Registry

NCT00099541

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Birmingham Hematology and Oncology Associates Birmingham, Alabama, United States
  • Hembree Cancer Center-St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Pacific Cancer Medical Center Inc. Anaheim, California, United States
  • Bay Area Cancer Research Group Concord, California, United States
View all 101 locations
View Trial Details

Related conditions